About Cytokinetics (CYTK)
Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compr... Read more
- USD39.98
- USD40.84
- USD39.33
- USD68.44
- -13.40%
- 18M
- 893.39k
- 2.49M
- 4.7B
- 32.74
- -39.60%
Stock News
yesterday
Where Trump’s tariffs and economic promises stand as he nears 100 days in office
MarketWatch
yesterday
Why Universal Logistics (ULH) Stock Is Down Today
Yahoo
yesterday
38-year-old turned his New York apartment into a 'spice warehouse'—now his company brings in $8 million a year
CNBC
yesterday
We're putting a big weekly winner in the Bullpen but see more room for the stock to run
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
